<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Urol.</journal-id>
<journal-title>Frontiers in Urology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Urol.</abbrev-journal-title>
<issn pub-type="epub">2673-9828</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fruro.2025.1651449</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Urology</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Metal urethral stent placement for the management of urethral stricture following phalloplasty: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Hu</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2250572/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Chuanhua</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Qiang</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Yongsheng</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Longchao</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Lulu</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xin</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pan</surname>
<given-names>Jinhong</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Heng</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2577964/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Urology, Guiqian International General Hospital</institution>, <addr-line>Guiyang</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Pedro Abreu-Mendes, Centro Hospitalar de Entre o Douro e Vouga E.P.E., Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Menghua Wang, Sichuan University, China</p>
<p>Ershad Hussain Galeti, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Heng Zhang, <email xlink:href="mailto:zzdn2022@163.com">zzdn2022@163.com</email>; Jinhong Pan, <email xlink:href="mailto:panjh765@163.com">panjh765@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>5</volume>
<elocation-id>1651449</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 He, Zhong, Chen, Lei, Chen, Li, Zhang, Pan and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>He, Zhong, Chen, Lei, Chen, Li, Zhang, Pan and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To report the preliminary experience of a case in which a thermo-expandable nickel-titanium shape memory alloy metal stent was utilized for the management of urethral stricture following phalloplasty.</p>
</sec>
<sec>
<title>Methods</title>
<p>A 51-year-old male patient underwent lower abdominal island flap phalloplasty due to penile trauma. Postoperative recurrent dysuria occurred, and urethrography revealed stricture at the urethral anastomosis site near the penile root. A thermo-expandable nickel-titanium shape memory alloy metal stent was implanted.</p>
</sec>
<sec>
<title>Results</title>
<p>The patient underwent a successful surgical procedure. One day after the surgery, the urethral catheter was removed, and the patient resumed normal urination. After achieving satisfactory outcomes, the patient recovered and was discharged. During regular follow-up visits after discharge, the patient maintained unobstructed urination without weak urine stream or other discomforts.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The placement of a thermo-expandable nickel-titanium shape memory alloy metal stent offers a novel treatment option for patients with urethral stricture following phalloplasty</p>
</sec>
</abstract>
<kwd-group>
<kwd>phalloplasty</kwd>
<kwd>urethral stricture</kwd>
<kwd>stent placement</kwd>
<kwd>difficulty urinating</kwd>
<kwd>thermo-expandable nickel-titanium shape memory alloy metal stent</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="7"/>
<page-count count="4"/>
<word-count count="1070"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Male Urology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Urethral stricture following phalloplasty is one of the common complications in patients undergoing phalloplasty due to penile trauma. The stricture primarily occurs at the urethral anastomotic site near the penile root. Due to its unique anatomical characteristics and clinical complexity, the treatment of such condition remains relatively challenging. This article presents a case from the Department of Urology at Guiqian International General Hospital, where a patient with urethral stricture following phalloplasty underwent placement of a thermo-expandable nickel-titanium shape memory alloy stent. The details are reported as follows.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Clinical data</title>
<p>The patient, a 51-year-old male, was admitted to the hospital due to &#x201c;dysuria for 14 years, aggravated with fever for 1 day&#x201d;. Medical history: 20 years ago, the patient underwent lower abdominal island flap phalloplasty at another hospital due to penile trauma. Dysuria occurred 6 years after the surgery. The patient underwent repeated urethral dilation treatments, but exhibited poor response. Physical examination revealed a visible old surgical scar on the left abdomen and postoperative appearance of the phalloplasty (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1a</bold>
</xref>). Urethrography after admission demonstrated localized stricture at the anastomotic site of the short urethra in the reconstructed penis (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1b</bold>
</xref>). Urethrocystoscopy showed multiple trabeculae formation in the bladder and stenosis was seen at the urethral anastomosis (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1c</bold>
</xref>). The patient requested the placement of a thermo-expandable nickel-titanium shape memory alloy metal stent. Following urethral dilation under general anesthesia, a 26Fr cystoscope was inserted transurethrally. A urethral metal stent kit was deployed, and a 5 cm urethral metal stent (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>) was placed under direct visualization, with the proximal end approximately 2 cm from the urethral sphincter. The stent fully covered the anastomotic stricture and scarred segment of the urethra. The kit was withdrawn, and urethroscopy confirmed proper stent placement (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1d</bold>
</xref>). An 8Fr single-lumen urethral catheter was indwelled, and the procedure concluded. One day after the surgery, the urethral catheter was removed, and the patient resumed normal urination (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1f</bold>
</xref>) without urinary incontinence or other discomforts. One month after the surgery, the patient returned to the hospital for a follow-up examination, and the urethrography revealed that after the placement of the urethral metal stent, the contrast agent passed smoothly through the previous stricture at the urethral anastomotic site (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1e</bold>
</xref>). During the follow-up period, the patient had unobstructed urination without adverse complications such as weak urine stream or urinary incontinence.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Clinical presentation, imaging findings, intraoperative, and postoperative features of a patient with urethral stricture. <bold>(a)</bold> Postoperative appearance of reconstructed penis <bold>(b)</bold> Schematic diagram of preoperative urethrography <bold>(c)</bold> Urethral stricture during surgery <bold>(d)</bold> Metal stent placed during surgery <bold>(e)</bold> Schematic diagram of postoperative urethrography <bold>(f)</bold> Postoperative urination condition.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fruro-05-1651449-g001.tif">
<alt-text content-type="machine-generated">A collage of six images labeled a to f: (a) postoperative view of a lower abdomen with a surgical scar, (b) X-ray showing a filled bladder, (c) endoscopic view of a urethral channel, (d) circular object with concentric patterns, (e) X-ray showing a tubular structure connected to the bladder, (f) person urinating.</alt-text>
</graphic>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Appearance diagram of urethral metal stent.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fruro-05-1651449-g002.tif">
<alt-text content-type="machine-generated">Medical equipment consisting of a red and white valve assembly connected to a clear tube, flanked by two coiled transparent tubes in packaging. Two gray ribbed inserts are positioned beside the central tube. The setup lays on a blue fabric background.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussions</title>
<p>Phalloplasty is a crucial surgical approach to address urinary and sexual function needs in patients with penile defects caused by trauma, tumor resection, or congenital deformities, while also improving their psychological well-being. The main surgical techniques include the tubed flap method, pedicled flap method, free flap method, Cheng&#x2019;s method, and composite free flap method (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Urethral stricture is a common complication following phalloplasty (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Its pathogenesis is primarily associated with the characteristics of urethral reconstruction materials (mainly skin grafts): compared to native urethral mucosa, the thin epithelial layer and thick dermal layer of skin are more prone to significant scar formation. Poor healing and scar contracture serve as the fundamental causes of urethral stricture.</p>
<p>Urethral stricture may lead to severe complications such as hydronephrosis, recurrent urinary tract infections, and urinary retention. The current treatment options include periodic urethral dilation, urethroplasty, cystostomy, perineal urethrostomy, etc. However, the application of metal urethral stents for the management of urethral strictures secondary to phalloplasty has not been reported either in domestic or foreign literature, and there is currently a lack of unified guidelines or consensus for its diagnosis and treatment.</p>
<p>The Memokath&#x2122; third-generation spiral stent is made of nickel-titanium shape memory alloy and features unique thermodynamic properties: It expands and reshapes to anchor within the urethra when exposed to 55&#xb0;C warm water. Unlike early mesh stents, its spiral structure minimizes tissue overgrowth <italic>in vivo</italic>. When cooled in 5&#xb0;C ice water, the stent contracts and softens, which facilitates removal. The urethral stent offers advantages such as a relatively simple implantation procedure, high survivorship, excellent wear resistance, superior safety profile, and fewer complications (<xref ref-type="bibr" rid="B5">5</xref>). It has been applied in treating voiding dysfunction caused by benign prostatic hyperplasia (<xref ref-type="bibr" rid="B6">6</xref>) and prostate cancer (<xref ref-type="bibr" rid="B7">7</xref>). The patient in this case experienced long-term recurrent urethral stricture following phalloplasty, and showed poor response to conventional dilation therapy. We utilized the Memokath&#x2122; thermo-expandable nickel-titanium shape memory alloy stent for treatment, with preliminary results demonstrating its effectiveness in relieving reconstructed urethral anastomotic strictures and restoring unobstructed urination. During short-term follow-up (up to the submission date), no occurrences of common complications such as stent migration, urinary incontinence, or recurrent infections were observed. Compared to repeated urethral dilation or urethroplasty requiring complex flap repair, this minimally invasive approach may offer a novel and less traumatic treatment option for specific patients, which avoids the pain associated with repeated procedures and the uncertainty surrounding therapeutic outcomes.</p>
<p>According to literature review, this case represents the first reported instance in China of successfully placing a thermo-expandable nickel-titanium shape memory alloy stent (Memokath&#x2122;) under direct cystoscopic vision for the management of urethral stricture following phalloplasty. This case has provided preliminary confirmation of the feasibility and short-term efficacy of this technology. With advancements in minimally invasive urological techniques and the emergence of novel devices, there have been more treatment options available for complex urethral strictures (including reconstructed urethral strictures). However, its long-term safety, efficacy, and applicable populations still require further evaluation through studies with larger sample sizes and extended follow-up.</p>
</sec>
</body>
<back>
<sec id="s4" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s5" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>HH: Resources, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CZ: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. QC: Data curation, Formal Analysis, Writing &#x2013; review &amp; editing. YL: Investigation, Methodology, Writing &#x2013; review &amp; editing. LC: Conceptualization, Data curation, Writing &#x2013; review &amp; editing. LL: Conceptualization, Methodology, Writing &#x2013; review &amp; editing. XZ: Conceptualization, Data curation, Writing &#x2013; review &amp; editing. JP:&#xa0;Conceptualization, Resources, Writing &#x2013; review &amp; editing. HZ: Conceptualization, Resources, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garaffa</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sansalone</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ralph</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Penile reconstruction</article-title>. <source>Asian J Androl</source>. (<year>2013</year>) <volume>15</volume>:<page-range>16&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/aja.2012.9</pub-id>, PMID: <pub-id pub-id-type="pmid">22426595</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yulin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wensen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shuzhong</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Selection of surgical methods for phalloplasty</article-title>. <source>J Clin Surg</source>. (<year>2016</year>) <volume>24</volume>:<page-range>171&#x2013;2</page-range>.</citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esmonde</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bluebond-Langner</surname> <given-names>R</given-names>
</name>
<name>
<surname>Berli</surname> <given-names>JU</given-names>
</name>
</person-group>. <article-title>Phalloplasty flap-related complication</article-title>. <source>Clin Plast Surg</source>. (<year>2018</year>) <volume>45</volume>:<page-range>415&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cps.2018.03.017</pub-id>, PMID: <pub-id pub-id-type="pmid">29908631</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yede</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xudong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Qiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Qinglian</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Experience in the management of urethral stricture following phalloplasty</article-title>. <source>J Navy Med</source>. (<year>2010</year>) <volume>31</volume>:<page-range>242&#x2013;3</page-range>.</citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedigh</surname> <given-names>O</given-names>
</name>
<name>
<surname>Dalmasso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Barale</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pizzuto</surname> <given-names>G</given-names>
</name>
<name>
<surname>Agosti</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dadone</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>UVENTA urethral stents: Are we taking a step forward? The first clinical series</article-title>. <source>Arch Esp Urol</source>. (<year>2021</year>) <volume>74</volume>:<page-range>435&#x2013;40</page-range>., PMID: <pub-id pub-id-type="pmid">33942736</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerrato</surname> <given-names>C</given-names>
</name>
<name>
<surname>Antoniou</surname> <given-names>V</given-names>
</name>
<name>
<surname>Somani</surname> <given-names>BK</given-names>
</name>
</person-group>. <article-title>Prostatic stents: a systematic review and analysis of functionaloutcomes and complication rate</article-title>. <source>Prostatic Dis</source>. (<year>2025</year>) <volume>28</volume>:<page-range>318&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41391-024-00915-y</pub-id>, PMID: <pub-id pub-id-type="pmid">39516581</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kyung</surname> <given-names>YS</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy and tolerability of metallic stent in patients with Malignant prostatic obstruction secondary to prostatic cancer</article-title>. <source>Low Urin Tract Symptoms</source>. (<year>2021</year>) <volume>13</volume>:<page-range>329&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/luts.12367</pub-id>, PMID: <pub-id pub-id-type="pmid">33768708</pub-id></citation></ref>
</ref-list>
</back>
</article>